Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
货号（Catalog No.）
CSD00197
通用名INN
Solanezumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
别名(Alternative names)
LY2062430
靶点;物种(Specificity target name;species)
APP Abeta,soluble monomer[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG1-kappa
化学信息
CAS
955085-14-0
存储条件(Storage)
store at -80°C

Note
For research use only. Not suitable for clinical or therapeutic use.